3. 1-2 %
Risk factors
Positive family/past history
Low socioeconomic status
HighTB prevalence area
HIV infection
IV drug abuse
Diabetes
4. Pregnancy aggravatedTB
Lesions remain same
Same mortality rate for pregnant and non-
pregnantTB women (treated)
No increase in relapse
No increase in risk of activeTB in HIV (+)ve
mothers
5. Affect fertility if associated with genitalTB
Slight increase in abortion, IUGR and preterm
labour
Rare transplacental infection
Neonatal infection mainly by postpartum
maternal contact or aspiration of amniotic
fluid
6. May be delayed
(nonspecific early
symptoms)
Cough, haemoptysis,
fever, weight loss
Any
pregnant/puerperal
women with
unexplained cough and
sputum
Tuberculin skin test
Chest X-ray (>12w)
Early morning sputum
for AFB
Gastric washings
Diagnostic
bronchoscopy
Direct amplification
tests
7.
8. Lesion in first week of life
Primary hepatic complex / caseating hepatic
granuloma by percutaneous liver biopsy at
birth
Infection in maternal genital tract or placenta
No evidence of post natal transmission
9.
10. Prophylaxis
Asymptomatic women (>35y/o) with (+)ve
PPD
Isoniazid 300mg/day after 1st trimester for 6-9
months
Pyridoxine 50 mg/day
13. Therapeutic termination:
maybe in MDR-TB
Avoid breastfeeding if mother and child is on
drugs
Prophylaxis for baby if mother have activeTB
isoniazid 10-20 mg/kg/day for 3 months till
mother become sputum (-) ve.
BCG given as soon as possible.
Avoid pregnancy till two years of quiescence
Avoid OCP with rifampicin
14.
15. Tropical disease causing complication in
pregnancy.
Female Anopheles mosquito
Haemolysis of RBC and microcirculation
blockage due to sequestrated RBC.
Pregnancy increases risk, severity and
complication of infection
16.
17. MOTHER
Megaloblastic anemia
Hypoglycemia
Metabolic acidosis
Jaundice
Renal failure
Pulmonary edema
Cerebral malaria
FETUS
Due to high fever and
placental parasitization.
Mostly in p. falciparum
infection and 2nd half of
pregnancy.
Abortion, preterm labor,
IUGR and IUFD
Congenital malaria is rare
unless placenta is damaged
18.
19. Prevention
▪ Pyrethroid-impregnated mosquito nets
▪ Electrically heated mats
▪ Chloroquine 300mg weekly
▪ Mefloquine 250mg/week ( chloroquine-
resistant)
▪ from 2 weeks before travel to 4 weeks after
travel.
20. Chloroquine
▪ 10 mg base/kg PO
▪ 10mg/kg at 24 hours
▪ 5mg/kg at 48 hours
Primaquin (radical cure) postponed till end of
pregnancy
Quinine ( chloroquine-resistant) 10 mg salt/ kg
every 8 hours for 7 days
Folic acid 10mg daily
21. IV artesunate 2.4mg/kg at 0 ,12 , 24 hours , then
daily
Oral artesunate 2mg/kg starts when patient is
stable
IV quinine can also be given
Limited use
▪ Only in 2nd or 3rd trimester when other drugs are
resistant
22.
23. Cross placenta congenital/neonatal
chickenpox
High maternal mortality due to varicella
pneumonia
26. Live attenuated varicella vaccine not
recommended
Varicella Zoster Immunoglobulin to
exposed non-immune person
Newborn exposed within 5 days of delivery
Oral acyclovir ( within 24 hours ) decrease
illness duration
27. IntracellularGm (+)ve bacillus
In soil and vegetation
Eating infected food/ animal products
Reliable serological test: blood culture during
septicemia
28. Flu-like/ food poisoning maternal symptoms
Obstretric complication:
Late miscarriage ,preterm labor, stillbirth
Neonatal death (10%)
30. Hookworms : 700-900 million worldwide
Roundworms : 25% of world’s population
Most common infestation in tropics
Diagnosis: stool examination
Treatment :
deworming ( excluding 1st trimester)
Iron therapy for anemia